Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

INMD vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
INMD
InMode Ltd.

Medical - Devices

HealthcareNASDAQ • IL
Market Cap$861M
5Y Perf.-7.3%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$160.44B
5Y Perf.+133.6%

INMD vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
INMD logoINMD
ISRG logoISRG
IndustryMedical - DevicesMedical - Instruments & Supplies
Market Cap$861M$160.44B
Revenue (TTM)$370M$10.58B
Net Income (TTM)$94M$2.98B
Gross Margin78.5%66.3%
Operating Margin23.0%30.5%
Forward P/E9.4x43.7x
Total Debt$13M$303M
Cash & Equiv.$303M$3.37B

INMD vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

INMD
ISRG
StockMay 20May 26Return
InMode Ltd. (INMD)10092.7-7.3%
Intuitive Surgical,… (ISRG)100233.6+133.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: INMD vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ISRG leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. InMode Ltd. is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
INMD
InMode Ltd.
The Value Pick

INMD is the clearest fit if your priority is valuation efficiency.

  • PEG 0.95 vs ISRG's 2.01
  • Lower P/E (9.4x vs 43.7x), PEG 0.95 vs 2.01
  • -5.0% vs ISRG's -14.8%
Best for: valuation efficiency
ISRG
Intuitive Surgical, Inc.
The Income Pick

ISRG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • beta 1.02
  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 5.6% 10Y total return vs INMD's 100.1%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs INMD's -6.2%
ValueINMD logoINMDLower P/E (9.4x vs 43.7x), PEG 0.95 vs 2.01
Quality / MarginsISRG logoISRG28.2% margin vs INMD's 25.3%
Stability / SafetyISRG logoISRGBeta 1.02 vs INMD's 1.04, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)INMD logoINMD-5.0% vs ISRG's -14.8%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs INMD's 12.9%, ROIC 15.0% vs 13.5%

INMD vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

INMDInMode Ltd.
FY 2025
Capital Equipment
100.0%$289M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

INMD vs ISRG — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGINMD

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 5 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 28.6x INMD's $370M. Profitability is closely matched — net margins range from 28.2% (ISRG) to 25.3% (INMD). On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$370M$10.6B
EBITDAEarnings before interest/tax$86M$3.8B
Net IncomeAfter-tax profit$94M$3.0B
Free Cash FlowCash after capex$89M$2.8B
Gross MarginGross profit ÷ Revenue+78.5%+66.3%
Operating MarginEBIT ÷ Revenue+23.0%+30.5%
Net MarginNet income ÷ Revenue+25.3%+28.2%
FCF MarginFCF ÷ Revenue+24.1%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+6.1%+23.0%
EPS Growth (YoY)Latest quarter vs prior year-63.2%+18.8%
ISRG leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

INMD leads this category, winning 7 of 7 comparable metrics.

At 9.5x trailing earnings, INMD trades at a 83% valuation discount to ISRG's 57.4x P/E. Adjusting for growth (PEG ratio), INMD offers better value at 0.96x vs ISRG's 2.64x — a lower PEG means you pay less per unit of expected earnings growth.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…
Market CapShares × price$861M$160.4B
Enterprise ValueMkt cap + debt − cash$572M$157.4B
Trailing P/EPrice ÷ TTM EPS9.50x57.40x
Forward P/EPrice ÷ next-FY EPS est.9.41x43.67x
PEG RatioP/E ÷ EPS growth rate0.96x2.64x
EV / EBITDAEnterprise value multiple6.64x43.44x
Price / SalesMarket cap ÷ Revenue2.32x15.94x
Price / BookPrice ÷ Book value/share1.30x9.13x
Price / FCFMarket cap ÷ FCF10.22x64.42x
INMD leads this category, winning 7 of 7 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 7 of 8 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $15 for INMD. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to INMD's 0.02x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs INMD's 3/9, reflecting solid financial health.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity+14.5%+16.9%
ROA (TTM)Return on assets+12.9%+14.8%
ROICReturn on invested capital+13.5%+15.0%
ROCEReturn on capital employed+12.1%+16.5%
Piotroski ScoreFundamental quality 0–936
Debt / EquityFinancial leverage0.02x0.02x
Net DebtTotal debt minus cash-$289M-$3.1B
Cash & Equiv.Liquid assets$303M$3.4B
Total DebtShort + long-term debt$13M$303M
Interest CoverageEBIT ÷ Interest expense
ISRG leads this category, winning 7 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $16,086 today (with dividends reinvested), compared to $3,608 for INMD. Over the past 12 months, INMD leads with a -5.0% total return vs ISRG's -14.8%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.2% vs INMD's -27.0% — a key indicator of consistent wealth creation.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date-8.2%-19.6%
1-Year ReturnPast 12 months-5.0%-14.8%
3-Year ReturnCumulative with dividends-61.1%+49.0%
5-Year ReturnCumulative with dividends-63.9%+60.9%
10-Year ReturnCumulative with dividends+100.1%+556.9%
CAGR (3Y)Annualised 3-year return-27.0%+14.2%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — INMD and ISRG each lead in 1 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than INMD's 1.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. INMD currently trades 81.2% from its 52-week high vs ISRG's 74.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5001.04x1.02x
52-Week HighHighest price in past year$16.74$603.88
52-Week LowLowest price in past year$12.72$427.84
% of 52W HighCurrent price vs 52-week peak+81.2%+74.8%
RSI (14)Momentum oscillator 0–10056.042.2
Avg Volume (50D)Average daily shares traded788K1.8M
Evenly matched — INMD and ISRG each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates INMD as "Buy" and ISRG as "Buy". Consensus price targets imply 37.8% upside for ISRG (target: $623) vs 17.7% for INMD (target: $16).

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$16.00$622.60
# AnalystsCovering analysts1155
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+14.8%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). INMD leads in 1 (Valuation Metrics). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 3 of 6 categories
Loading custom metrics...

INMD vs ISRG: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is INMD or ISRG a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -6. 2% for InMode Ltd. (INMD). InMode Ltd. (INMD) offers the better valuation at 9. 5x trailing P/E (9. 4x forward), making it the more compelling value choice. Analysts rate InMode Ltd. (INMD) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — INMD or ISRG?

On trailing P/E, InMode Ltd.

(INMD) is the cheapest at 9. 5x versus Intuitive Surgical, Inc. at 57. 4x. On forward P/E, InMode Ltd. is actually cheaper at 9. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: InMode Ltd. wins at 0. 95x versus Intuitive Surgical, Inc. 's 2. 01x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — INMD or ISRG?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +60. 9%, compared to -63. 9% for InMode Ltd. (INMD). Over 10 years, the gap is even starker: ISRG returned +556. 9% versus INMD's +100. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — INMD or ISRG?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 02β versus InMode Ltd. 's 1. 04β — meaning INMD is approximately 2% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 2% for InMode Ltd. — giving it more financial flexibility in a downturn.

05

Which is growing faster — INMD or ISRG?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus -6. 2% for InMode Ltd. (INMD). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to -36. 4% for InMode Ltd.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — INMD or ISRG?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus 25. 3% for InMode Ltd. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus 23. 0% for INMD. At the gross margin level — before operating expenses — INMD leads at 78. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is INMD or ISRG more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, InMode Ltd. (INMD) is the more undervalued stock at a PEG of 0. 95x versus Intuitive Surgical, Inc. 's 2. 01x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, InMode Ltd. (INMD) trades at 9. 4x forward P/E versus 43. 7x for Intuitive Surgical, Inc. — 34. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 8% to $622. 60.

08

Which pays a better dividend — INMD or ISRG?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is INMD or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +556. 9% 10Y return). Both have compounded well over 10 years (ISRG: +556. 9%, INMD: +100. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between INMD and ISRG?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: INMD is a small-cap deep-value stock; ISRG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

INMD

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 15%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform INMD and ISRG on the metrics below

Revenue Growth>
%
(INMD: 6.1% · ISRG: 23.0%)
Net Margin>
%
(INMD: 25.3% · ISRG: 28.2%)
P/E Ratio<
x
(INMD: 9.5x · ISRG: 57.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.